Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 Mar 2017 09:33:00 AM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1270.35 [ -0.23% ]TCS 2455.00 [ -0.22% ]

Sensex29437.64
105.48 0.36%

Nifty9099.40
13.10 0.14%

Midcap13904.70
51.30 0.37%

Smallcap14115.46
87.52 0.62%


Bse Corporate Announcements Back
Sun Pharmaceuticals received tentative approval for the Ibandronate Sodium injection
Sun Pharmaceuticals received tentative approval for the Ibandronate Sodium injection Sun Pharmaceuticals received tentative approval for the Abbreviated New Drug Application (ANDA) from US Food and Drug Application for the Ibandronate Sodium 1mg/ml injection. It was originally developed and marketed by the Roche under the brand name drug Boniva. The drug is used to treat or prevent osteoporosis in women after menopause. According to Roche Half year report, the drug sales fell by 17% to 394 million CHF (Swiss francs) for the six months ended June 2011. Also, Teva Pharmaceuticals has already received tentative approval in the same strength.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com